{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:51:17Z","timestamp":1785894677255,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The delayed or missed diagnosis of secondary hypertension contributes to the poor blood pressure control worldwide. This study aimed to assess the diagnostic approach to primary aldosteronism (PA) and pheochromocytoma (PHEO) among Italian centers associated to European and Italian Societies of Hypertension.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Between July and December 2023, a 10-items questionnaire was administered to experts from 82 centers of 14 Italian regions and to cardiologists from the ARCA (Associazioni Regionali Cardiologi Ambulatoriali) Piemonte. Results were stratified for geographical area, specialty, and center category (excellence vs. non-excellence centers).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Each center diagnosed an average of 2 cases of PA and 0.2 cases of PHEO annually, with higher figures in excellence centers. PA screening is performed mainly in patients with resistant hypertension (73.2%) or hypertension and spontaneous hypokalemia (84.1%), while only 17.1% and 35.4% of centers screen patients with grade 2\u20133 hypertension. Screening rate is lower for cardiologists compared to other specialists. The main barriers to wider testing were challenges in interpreting the aldosterone\/renin ratio under interfering medications and switching to non-interfering drugs. Clinical scores to predict the likelihood of PA and the definition of Standard Operating Procedures were identified as potential tools to boost screening rates. Testing for PHEO was mostly conducted in patients with typical symptoms (75.6%) and\/or hypertensive crisis (74.4%). Only 37.8% of centers screened all patients with adrenal incidentaloma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study highlights significant gaps in the screening and diagnosis of PA and PHEO across Italian centers and underscores the need for widespread and standardized diagnostic protocols.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40618-025-02532-5","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T06:20:37Z","timestamp":1737181237000},"page":"1197-1205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Screening of primary aldosteronism and pheochromocytoma among patients with hypertension: an Italian nationwide survey"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-2005","authenticated-orcid":false,"given":"Silvia","family":"Monticone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Goi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Burrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Di Dalmazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo F. G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Coletti","family":"Moia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Italian Society of Arterial Hypertension (SIIA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"10060","key":"2532_CR1","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","volume":"388","author":"MH Olsen","year":"2016","unstructured":"Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Gimenez-Roqueplo AP, Hering D, L\u00f3pez-Jaramillo P, Martinez F, Perkovic V, Rietzschel ER, Schillaci G, Schutte AE, Scuteri A, Sharman JE, Wachtell K, Wang JG (2016) A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 388(10060):2665\u20132712. https:\/\/doi.org\/10.1016\/S0140-6736(16)31134-5","journal-title":"Lancet"},{"issue":"14","key":"2532_CR2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, Gabetti L, Mengozzi G, Williams TA, Rabbia F, Veglio F, Mulatero P (2017) Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 69(14):1811\u20131820. https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2532_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Xu Z, Yang J, Hu J, Song Y, He W, Luo T, Cheng Q, Ma L, Luo R, Fuller PJ, Cai J, Li Q, Yang S (2020) Chongqing Primary Aldosteronism Study (CONPASS) Group. Primary aldosteronism in patients in China with recently detected hypertension. J Am Coll Cardiol 75(16):1913\u20131922. https:\/\/doi.org\/10.1016\/j.jacc.2020.02.052","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2532_CR4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.hyp.0000040261.30455.b6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P (2002) Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40(6):892\u2013896. https:\/\/doi.org\/10.1161\/01.hyp.0000040261.30455.b6","journal-title":"Hypertension"},{"issue":"9628","key":"2532_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C (2008) Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371(9628):1921\u20131926. https:\/\/doi.org\/10.1016\/S0140-6736(08)60834-X","journal-title":"Lancet"},{"issue":"4","key":"2532_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","volume":"75","author":"J Burrello","year":"2020","unstructured":"Burrello J, Monticone S, Losano I, Cavagli\u00e0 G, Buffolo F, Tetti M, Covella M, Rabbia F, Veglio F, Pasini B, Williams TA, Mulatero P (2020) Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit. Hypertension 75(4):1025\u20131033. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14063","journal-title":"Hypertension"},{"issue":"1","key":"2532_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","volume":"38","author":"S Monticone","year":"2020","unstructured":"Monticone S, Sconfienza E, D\u2019Ascenzo F, Buffolo F, Satoh F, Sechi LA, Veglio F, Mulatero P (2020) Renal damage in primary aldosteronism: a systematic review and meta-analysis. J Hypertens 38(1):3\u201312. https:\/\/doi.org\/10.1097\/HJH.0000000000002216","journal-title":"J Hypertens"},{"issue":"1","key":"2532_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6(1):41\u201350. https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2532_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 6(1):51\u201359. https:\/\/doi.org\/10.1016\/S2213-8587(17)30367-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2532_CR10","doi-asserted-by":"publisher","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(5):1889\u2013\u2009916. https:\/\/doi.org\/10.1210\/jc.2015-4061. Epub 2016 Mar 2. PMID: 26934393","DOI":"10.1210\/jc.2015-4061"},{"issue":"10","key":"2532_CR11","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J (2020) Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 38(10):1919\u20131928. https:\/\/doi.org\/10.1097\/HJH.0000000000002510","journal-title":"J Hypertens"},{"issue":"3","key":"2532_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/M20-4873","volume":"174","author":"JB Cohen","year":"2021","unstructured":"Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V (2021) Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans: a retrospective cohort study. Ann Intern Med 174(3):289\u2013297. https:\/\/doi.org\/10.7326\/M20-4873","journal-title":"Ann Intern Med"},{"issue":"1","key":"2532_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","volume":"79","author":"GL Hundemer","year":"2022","unstructured":"Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, Agharazii M, Knoll G, Sood MM (2022) Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study. Hypertension 79(1):178\u2013186. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.18118","journal-title":"Hypertension"},{"issue":"3","key":"2532_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27(3):193\u2013202. https:\/\/doi.org\/10.1291\/hypres.27.193","journal-title":"Hypertens Res"},{"issue":"8","key":"2532_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","volume":"38","author":"JWM Lenders","year":"2020","unstructured":"Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers HJLM, Castinetti F, Dralle H, Widimsk\u00fd J, Gimenez-Roqueplo AP, Eisenhofer G (2020) Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 38(8):1443\u20131456. https:\/\/doi.org\/10.1097\/HJH.0000000000002438","journal-title":"J Hypertens"},{"issue":"4","key":"2532_CR16","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1210\/jc.2004-1398","volume":"90","author":"L Amar","year":"2005","unstructured":"Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF (2005) Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 90(4):2110\u20132116. https:\/\/doi.org\/10.1210\/jc.2004-1398","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2532_CR17","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1038\/s41440-023-01461-1","volume":"46","author":"JB de Freminville","year":"2023","unstructured":"de Freminville JB, Amar L, Azizi M, Mallart-Riancho J (2023) Endocrine causes of hypertension: literature review and practical approach. Hypertens Res 46(12):2679\u20132692. https:\/\/doi.org\/10.1038\/s41440-023-01461-1","journal-title":"Hypertens Res"},{"issue":"1","key":"2532_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/EC-17-0321","volume":"7","author":"H Falhammar","year":"2018","unstructured":"Falhammar H, Kjellman M, Calissendorff J (2018) Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr Connect 7(1):186\u2013192. https:\/\/doi.org\/10.1530\/EC-17-0321","journal-title":"Endocr Connect"},{"issue":"5","key":"2532_CR19","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1210\/jc.2018-01707","volume":"104","author":"LM Gruber","year":"2019","unstructured":"Gruber LM, Hartman RP, Thompson GB, McKenzie TJ, Lyden ML, Dy BM, Young WF, Bancos I (2019) Pheochromocytoma characteristics and behavior differ depending on method of discovery. J Clin Endocrinol Metab 104(5):1386\u20131393. https:\/\/doi.org\/10.1210\/jc.2018-01707","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2532_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/HYPERTENSIONAHA.123.21902","volume":"81","author":"O Petr\u00e1k","year":"2024","unstructured":"Petr\u00e1k O, Kr\u00e1tk\u00e1 Z, Holaj R, Z\u00edtek M, Nguyen Nikr\u00fdnov\u00e1 T, Kl\u00edmov\u00e1 J, Kolo\u0161ov\u00e1 B, Waldauf P, Michalsk\u00fd D, Nov\u00e1k K, Markvartov\u00e1 A, Zlatohl\u00e1vek L, Grus T, Du\u0161kov\u00e1 J, Widimsk\u00fd J Jr, Zelinka T (2024) Cardiovascular complications in pheochromocytoma and paraganglioma: does phenotype matter? Hypertension 81(3):595\u2013603. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21902","journal-title":"Hypertension"},{"issue":"5","key":"2532_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/endrev\/bnad011","volume":"44","author":"G Eisenhofer","year":"2023","unstructured":"Eisenhofer G, Pamporaki C, Lenders JWM (2023) Biochemical assessment of pheochromocytoma and paraganglioma. Endocr Rev 44(5):862\u2013909. https:\/\/doi.org\/10.1210\/endrev\/bnad011","journal-title":"Endocr Rev"},{"issue":"11","key":"2532_CR22","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","volume":"34","author":"P Mulatero","year":"2016","unstructured":"Mulatero P, Monticone S, Burrello J, Veglio F, Williams TA, Funder J (2016) Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J Hypertens 34(11):2253\u20132257. https:\/\/doi.org\/10.1097\/HJH.0000000000001088","journal-title":"J Hypertens"},{"issue":"9","key":"2532_CR23","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","volume":"38","author":"M Parasiliti-Caprino","year":"2020","unstructured":"Parasiliti-Caprino M, Lopez C, Prencipe N, Lucatello B, Settanni F, Giraudo G, Rossato D, Mengozzi G, Ghigo E, Benso A, Maccario M (2020) Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension. J Hypertens 38(9):1841\u20131848. https:\/\/doi.org\/10.1097\/HJH.0000000000002441","journal-title":"J Hypertens"},{"key":"2532_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, Hanssen H, Harris J, Lauder L, McManus RJ, Molloy GJ, Rahimi K, Regitz-Zagrosek V, Rossi GP, Sandset EC, Scheenaerts B, Staessen JA, Uchmanowicz I, Volterrani M, Touyz RM, ESC Scientific Document Group (2024) 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J ehae178. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J ehae178"},{"issue":"8","key":"2532_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.5694\/mja2.51438","volume":"216","author":"R Libianto","year":"2022","unstructured":"Libianto R, Russell GM, Stowasser M, Gwini SM, Nuttall P, Shen J, Young MJ, Fuller PJ, Yang J (2022) Detecting primary aldosteronism in Australian primary care: a prospective study. Med J Aust 216(8):408\u2013412. https:\/\/doi.org\/10.5694\/mja2.51438","journal-title":"Med J Aust"},{"issue":"11","key":"2532_CR26","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1210\/clinem\/dgac460","volume":"107","author":"P Mulatero","year":"2022","unstructured":"Mulatero P, Bertello C, Veglio F, Monticone S (2022) Approach to the patient on antihypertensive therapy: screen for primary aldosteronism. J Clin Endocrinol Metab 107(11):3175\u20133181. https:\/\/doi.org\/10.1210\/clinem\/dgac460","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2532_CR27","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/HYPERTENSIONAHA.121.17444","volume":"78","author":"F Buffolo","year":"2021","unstructured":"Buffolo F, Burrello J, Burrello A, Heinrich D, Adolf C, M\u00fcller LM, Chen R, Forestiero V, Sconfienza E, Tetti M, Veglio F, Williams TA, Mulatero P, Monticone S (2021) Clinical score and machine learning-based model to Predict diagnosis of primary aldosteronism in arterial hypertension. Hypertension 78(5):1595\u20131604. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17444","journal-title":"Hypertension"},{"issue":"7","key":"2532_CR28","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1210\/clinem\/dgad044","volume":"108","author":"E Sconfienza","year":"2023","unstructured":"Sconfienza E, Tetti M, Forestiero V, Veglio F, Mulatero P, Monticone S (2023) Prevalence of functioning adrenal incidentalomas: a systematic review and Meta-analysis. J Clin Endocrinol Metab 108(7):1813\u20131823. https:\/\/doi.org\/10.1210\/clinem\/dgad044","journal-title":"J Clin Endocrinol Metab"},{"key":"2532_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02387-2","author":"G Di Dalmazi","year":"2024","unstructured":"Di Dalmazi G, Goi J, Burrello J, Tucci L, Cicero AFG, Mancusi C, Coletti Moia E, Iaccarino G, Borghi C, Muiesan ML, Ferri C, Mulatero P (2024) Screening of hypercortisolism among patients with hypertension: an Italian nationwide survey. J Endocrinol Invest doi. https:\/\/doi.org\/10.1007\/s40618-024-02387-2","journal-title":"J Endocrinol Invest doi"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02532-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02532-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02532-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T05:50:30Z","timestamp":1746251430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02532-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2532"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02532-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.M. received fees from Diasorin for educational speeches not related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}]}}